taurocholic acid has been researched along with Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asada, S; Imai, Y; Ishikawa, E; Sugimoto, Y; Tsukahara, S; Tsuruo, T | 1 |
| Andreyev, HJ; Lalji, A; Muls, AC; Phillips, F | 1 |
| Ağardan, NB; Altıntaş, L; Değim, Z; Topal, T; Yılmaz, Ş | 1 |
| Al-Hilal, TA; Alam, F; Byun, Y; Choi, JU; Hwang, SR; Jeong, JH; Kim, IS; Kim, SY; Mahmud, F; Park, J | 1 |
4 other study(ies) available for taurocholic acid and Breast Cancer
| Article | Year |
|---|---|
Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estrogens; Estrogens, Conjugated (USP); Estrone; LLC-PK1 Cells; Models, Molecular; Neoplasm Proteins; Sulfates; Swine | 2003 |
Are bile acid malabsorption and bile acid diarrhoea important causes of loose stool complicating cancer therapy?
Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Breast Neoplasms; Chemoradiotherapy; Diarrhea; Digestive System Neoplasms; Feces; Female; Hematologic Neoplasms; Humans; Malabsorption Syndromes; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Selenium Radioisotopes; Severity of Illness Index; Taurocholic Acid; Urogenital Neoplasms; Young Adult | 2015 |
The Effectiveness of Raloxifene-Loaded Liposomes and Cochleates in Breast Cancer Therapy.
Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Chemistry, Pharmaceutical; Female; Humans; Liposomes; Matrix Metalloproteinase 2; MCF-7 Cells; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Taurocholic Acid | 2016 |
Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate).
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Deoxycholic Acid; Epithelial-Mesenchymal Transition; Female; Heparin, Low-Molecular-Weight; Humans; Mice, SCID; Molecular Targeted Therapy; Neoplasm Metastasis; Phosphorylation; Taurocholic Acid; Transforming Growth Factor beta1 | 2016 |